Pancreatic Ductal Adenocarcinoma Overview

Save information for later
Sign Up

Learn About Pancreatic Ductal Adenocarcinoma

What is the definition of Pancreatic Ductal Adenocarcinoma?
Pancreatic ductal adenocarcinoma is an aggressive cancer that occurs in the linings of the tubes of the pancreas that carry enzymes to the intestines that assist with digestion.
What are the symptoms of Pancreatic Ductal Adenocarcinoma?
Early pancreatic ductal adenocarcinoma may not have any symptoms. Symptoms of pancreatic ductal adenocarcinoma may include yellowing of the skin and whites of the eyes, fatigue, dark urine, light-colored or greasy stools, itchy skin, abdominal or back pain, weight loss, nausea and vomiting, gallbladder or liver enlargement, blood clots, and diabetes.
Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Pancreatic Ductal Adenocarcinoma?
Treatment for pancreatic ductal adenocarcinoma includes surgery, radiation therapy, and chemotherapy.
Who are the top Pancreatic Ductal Adenocarcinoma Local Doctors?
Dr. Edward Dauterive
Gastroenterology
Dr. Edward Dauterive
Gastroenterology

Texas Digestive Disease Consultants PLLC

131 Cherokee Rose Ln, 
Covington, LA 
 (1.5 mi)
985-871-1721
Experience:
15+ years
Languages Spoken:
English
See accepted insurances

Edward Dauterive is a Gastroenterologist in Covington, Louisiana. Dr. Dauterive has been practicing medicine for over 15 years and is rated as an Experienced provider by MediFind in the treatment of Pancreatic Ductal Adenocarcinoma. His top areas of expertise are Acute Pancreatitis, Familial Pancreatic Cancer, Pancreatic Cancer, Endoscopy, and Hemorrhoidectomy.

Dr. Genevieve F. Maronge
Hematology | Oncology
Dr. Genevieve F. Maronge
Hematology | Oncology

Mary Bird Perkins Cancer Center

4950 Essen Ln, Suite 200, 
Baton Rouge, LA 
 (60.0 mi)
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Genevieve Maronge is a Hematologist and an Oncologist in Baton Rouge, Louisiana. Dr. Maronge and is rated as an Experienced provider by MediFind in the treatment of Pancreatic Ductal Adenocarcinoma. Her top areas of expertise are Paget Disease of the Breast, Ampullary Cancer, Lung Cancer, and Pleuropulmonary Blastoma. Dr. Maronge is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Dr. Allen R. Calabresi
Hematology Oncology | Hematology | Oncology
Dr. Allen R. Calabresi
Hematology Oncology | Hematology | Oncology

Ochsner Clinic LLC

1001 Gause Blvd, 
Slidell, LA 
 (23.7 mi)
985-646-5970
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Allen Calabresi is a Hematologist Oncology specialist and a Hematologist in Slidell, Louisiana. Dr. Calabresi and is rated as an Experienced provider by MediFind in the treatment of Pancreatic Ductal Adenocarcinoma. His top areas of expertise are Thrombocytopenia, Paget Disease of the Breast, Pleuropulmonary Blastoma, and Lung Cancer. Dr. Calabresi is currently accepting new patients.

View All Doctors
What are the latest Pancreatic Ductal Adenocarcinoma Clinical Trials?
Phase II/III Second-Line NABPLAGEM Vs. Nab-Paclitaxel/Gemcitabine in BRCA1/2 or PALB2 Mutant Metastatic Pancreatic Ductal Adenocarcinoma (PLATINUM)
Phase II/III Second-Line NABPLAGEM Vs. Nab-Paclitaxel/Gemcitabine in BRCA1/2 or PALB2 Mutant Metastatic Pancreatic Ductal Adenocarcinoma (PLATINUM)
Enrollment Status: Recruiting
Publish Date: January 13, 2025
Intervention Type: Procedure, Drug
Study Phase: Phase 2/Phase 3

Summary: This phase II/III trial compares the effect of the 3-drug chemotherapy combination of nab-paclitaxel, gemcitabine, plus cisplatin versus the 2-drug chemotherapy combination of nab-paclitaxel plus gemcitabine for the treatment of patients with pancreatic cancer that has spread to other places in the body (metastatic) and a known genetic mutation in the BRCA1, BRCA2, or PALB2 gene.

Match to trials
Find the right clinical trials for you in under a minute
Get started
Pilot Study of the Feasibility and Safety of a Personalized Peptide Vaccine in Patients With Advanced Pancreatic Ductal Adenocarcinoma or Colorectal Adenocarcinoma
Pilot Study of the Feasibility and Safety of a Personalized Peptide Vaccine in Patients With Advanced Pancreatic Ductal Adenocarcinoma or Colorectal Adenocarcinoma
Who is this study for: Adult patients with Colorectal Adenocarcinoma, Pancreatic Adenocarcinoma, Colorectal Cancer, or Pancreatic Cancer
Enrollment Status: Recruiting
Publish Date: January 10, 2025
Intervention Type: Procedure, Biological, Drug
Study Drugs: Imiquimod, Pembrolizumab, Synthetic Tumor-Associated Peptide Vaccine
Study Phase: Phase 1

Summary: This phase I trial studies the side effects and best way to give personalized peptide vaccine in patients with pancreatic or colorectal cancer that has spread to other places in the body and usually cannot be cured or controlled with treatment (advanced). Personalized peptide vaccine is a vaccine developed from patient's own tumor cells and blood in order to use as a biological therapy. Biological...

View All Clinical Trials